Transforming Allergy Treatment

Investor Relations

Corporate Documents

Click here to download the Articles of Association 20 November 2008

 

Allergy Therapeutics plc AIM Admission Document is published here in compliance with Rule 26 of the AIM Rules for Companies February 2007.

This admission document, which is not a prospectus, does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for Ordinary Shares in any jurisdiction in which such offer or solicitation is unlawful and, in particular, is not intended for distribution in or into the United States, Canada, Australia, Ireland, South Africa or Japan. The Ordinary Shares have not been and will not be registered under the United States Securities Act of 1933 (the “Securities Act”) as amended, or any state securities laws and, unless so registered, may not be offered or sold except pursuant to an exemption from, or in a transaction not subject to the registration requirements of, the Securities Act and applicable state securities laws. Nor have the securities been registered under the applicable securities laws of Canada, Australia, Ireland, South Africa or Japan. The distribution of this document in other jurisdictions may be restricted by law and therefore persons into whose possession this document comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities law of any such jurisdiction.

Click here to download the Admission document 6 October 2004